ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin

被引：108
|
作者：
Tomlinson, B. [1 ]
Hu, M. [1 ]
Lee, V. W. Y. [2 ]
Lui, S. S. H. [1 ]
Chu, T. T. W. [1 ]
Poon, E. W. M. [1 ]
Ko, G. T. C. [1 ,3 ]
Baum, L. [2 ]
Tam, L. S. [1 ]
Li, E. K. [1 ]
机构：
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷 / 05期
关键词：
COA REDUCTASE INHIBITORS; PHARMACOKINETICS; BCRP; PHARMACOGENETICS; ATORVASTATIN; TRANSPORTER; EXPRESSION; VARIANTS; GENOTYPE; OATP1B1;
D O I：
10.1038/clpt.2009.232
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The ATP-binding cassette G2 (ABCG2) c.421C>A (rs2231142) polymorphism influences the pharmacokinetics of rosuvastatin. We examined whether this polymorphism influences the low-density lipoprotein cholesterol (LDL-C)lowering efficacy of the drug. In 305 Chinese patients with hypercholesterolemia who were treated with rosuvastatin at a dosage of 10 mg daily, the c.421A variant was found to be significantly associated with greater reduction in LDL-C level, in a gene-dose-dependent manner. As compared with subjects with the c.421CC genotype, those with the c.421AA genotype showed a 6.9% greater reduction in LDL-C level, which would be equivalent to the effect obtained by doubling the dose of rosuvastatin.
引用
收藏
页码：558 / 562
页数：5
相关论文
共 50 条
  • [41] The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia
    Drouin-Chartier, Jean-Philippe
    Tremblay, Andre J.
    Bergeron, Jean
    Lamarche, Benoit
    Couture, Patrick
    CIRCULATION, 2017, 136 (09) : 880 - 882
  • [42] Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression
    Cha, Pei-Chieng
    Mushiroda, Taisei
    Zembutsu, Hitoshi
    Harada, Hiromasa
    Shinoda, Noriyuki
    Kawamoto, Shunji
    Shimoyama, Rai
    Nishidate, Toshihiko
    Furuhata, Tomohisa
    Sasaki, Kazuaki
    Hirata, Koichi
    Nakamura, Yusuke
    JOURNAL OF HUMAN GENETICS, 2009, 54 (10) : 572 - 580
  • [43] A Common Polymorphism in the FADS1 Locus Links miR1908 to Low-Density Lipoprotein Cholesterol Through BMP1
    Beehler, Kaitlyn
    Nikpay, Majid
    Lau, Paulina
    Anh-Thu Dang
    Lagace, Thomas A.
    Soubeyrand, Sebastien
    McPherson, Ruth
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (08) : 2252 - 2262
  • [44] Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote
    Wan, Zirui
    Wang, Guo
    Li, Tailin
    Xu, Biaobo
    Pei, Qi
    Peng, Yan
    Sun, Hong
    Cheng, Lijuan
    Zeng, Ying
    Yang, Guoping
    Zhu, Yuan-Shan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 354 (03) : 310 - 315
  • [45] Lack of Association between High-Density Lipoprotein Cholesterol and Angiographic Coronary Lesion Severity in Chinese Patients with Low Background Low-Density Lipoprotein Cholesterol
    Su, Chieh-Shou
    Chen, Kuan-Ju
    Sheu, Wayne Huey-Herng
    Yang, Ya-Ling
    Liu, Tsun-Jui
    Chang, Wei-Chun
    Wang, Kuo-Yang
    Lee, Wen-Lieng
    ACTA CARDIOLOGICA SINICA, 2015, 31 (06) : 528 - 535
  • [46] Are lower levels of low-density lipoprotein cholesterol beneficial? A review of recent data
    Olsson A.G.
    Current Atherosclerosis Reports, 2006, 8 (5) : 382 - 389
  • [47] Infection by Anaplasma phagocytophilum Requires Recruitment of Low-Density Lipoprotein Cholesterol by Flotillins
    Xiong, Qingming
    Lin, Mingqun
    Huang, Weiyan
    Rikihisa, Yasuko
    MBIO, 2019, 10 (02):
  • [48] LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOAL ATTAINMENT AMONG MALAYSIAN DYSLIPIDEMIC PATIENTS
    AL-khateeb, Alyaa
    Mohamed, Mohd Sapawi
    Imran, Kamarul
    Ibrahim, Suhairi
    Zilfalil, B. A., I
    Yusof, Zurkurnai
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (02) : 388 - 394
  • [49] Intensive reduction of low-density lipoprotein-cholesterol: Implications of recent trials
    Hackam D.G.
    American Journal of Cardiovascular Drugs, 2006, 6 (6) : 367 - 371
  • [50] More Progression Toward Regression? Beyond Low-Density Lipoprotein Cholesterol Lowering
    Lewis, Basil S.
    Halon, David A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (24) : 2743 - 2744
12345